Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
EuroBiotech Report
Biotech
EuroBiotech Report—Witty-WHO, Arix, Galapagos, Leo and Novartis
In this week's EuroBiotech Report, WHO taps Witty for COVID-19 project, Arix cuts costs and Galapagos hooks up with Ryvu.
Nick Paul Taylor
Apr 16, 2020 9:45am
EuroBiotech: More Articles of Note
Apr 16, 2020 9:30am
Arix cuts costs, changes leadership team to hunker down
Apr 10, 2020 8:11am
EuroBiotech Report—AZ, GSK, $8B funding call, CRUK and Evotec
Apr 9, 2020 9:07am
EuroBiotech: More Articles of Note
Apr 9, 2020 8:52am
AstraZeneca targets summer start for COVID-19 antibody trial
Apr 8, 2020 8:45am
